Drug Approval | March 07, 2022
NATCO launches first generic version of Revlimid in the US
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
Covaxin is not approved in the USA for any age group
Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations
USFDA's industry recommendations and cancer Moonshot aim to improve lives of patients and their families
Vonjo is the first approved therapy to specifically address the needs of adult cytopenic myelofibrosis patients
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad
New inhalers would have near-zero Global Warming Potential propellant
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
Subscribe To Our Newsletter & Stay Updated
